405 related articles for article (PubMed ID: 23839077)
41. Melanoma screening: Informing public health policy with quantitative modelling.
Gilmore S
PLoS One; 2017; 12(9):e0182349. PubMed ID: 28945758
[TBL] [Abstract][Full Text] [Related]
42. Changes from mid-1980s to late 1990s among clinical and demographic correlates of melanoma thickness.
Crocetti E; Carli P
Eur J Dermatol; 2003; 13(1):72-5. PubMed ID: 12609787
[TBL] [Abstract][Full Text] [Related]
43. Prognosis for patients with thin cutaneous melanoma: long-term survival data from New South Wales Central Cancer Registry and the Sydney Melanoma Unit.
McKinnon JG; Yu XQ; McCarthy WH; Thompson JF
Cancer; 2003 Sep; 98(6):1223-31. PubMed ID: 12973846
[TBL] [Abstract][Full Text] [Related]
44. Epidemiological changes in cutaneous melanoma: retrospective study of 969 cases (1996-2010).
Avilés-Izquierdo JA; Lázaro-Ochaita P; Suárez-Fernández R; Márquez-Rodas I; Parra-Blanco V; Escat-Cortés JL
Rev Clin Esp (Barc); 2013 Mar; 213(2):81-7. PubMed ID: 22874464
[TBL] [Abstract][Full Text] [Related]
45. Development of prognostic factors and survival in cutaneous melanoma over 25 years: An analysis of the Central Malignant Melanoma Registry of the German Dermatological Society.
Buettner PG; Leiter U; Eigentler TK; Garbe C
Cancer; 2005 Feb; 103(3):616-24. PubMed ID: 15630700
[TBL] [Abstract][Full Text] [Related]
46. Prognostic factors for cutaneous malignant melanoma in Vaud, Switzerland.
Levi F; Randimbison L; La Vecchia C; Te VC; Franceschi S
Int J Cancer; 1998 Oct; 78(3):315-9. PubMed ID: 9766565
[TBL] [Abstract][Full Text] [Related]
47. Trends in prognostic factors and survival from cutaneous melanoma in Yorkshire, UK and New South Wales, Australia between 1993 and 2003.
Downing A; Yu XQ; Newton-Bishop J; Forman D
Int J Cancer; 2008 Aug; 123(4):861-6. PubMed ID: 18500743
[TBL] [Abstract][Full Text] [Related]
48. Distribution of clinical-pathological types of cutaneous melanomas and mortality rate in the region of Passo Fundo, RS, Brazil.
Borges SZ; Bakos L; Cartell A; Wagner M; Agostini A; Lersch E
Int J Dermatol; 2007 Jul; 46(7):679-86. PubMed ID: 17614794
[TBL] [Abstract][Full Text] [Related]
49. Geographical variation of incidence of cutaneous melanoma in Queensland.
Buettner PG; MacLennan R
Aust J Rural Health; 2008 Oct; 16(5):269-77. PubMed ID: 18808484
[TBL] [Abstract][Full Text] [Related]
50. A 10-Year Follow-Up Study of Subjects Recruited in a Health Campaign for the Early Diagnosis of Cutaneous Melanoma: Suggestions for the Screening Timetable.
Cristofolini M; Boi S; Cattoni D; Sicher MC; Decarli A; Micciolo R
Dermatology; 2015; 231(4):345-52. PubMed ID: 26278413
[TBL] [Abstract][Full Text] [Related]
51. [Malignant melanoma of the skin: does screening for cancer influence the incidence and mortality?].
Schubert A
Gesundheitswesen; 2012 Mar; 74(3):154-9. PubMed ID: 21305450
[TBL] [Abstract][Full Text] [Related]
52. [Melanomas more serious in the elderly].
van der Meijden WA; van Bruchem-Visser RL; Thio HB; van der Cammen TJ
Ned Tijdschr Geneeskd; 2010; 154():A1535. PubMed ID: 20482904
[TBL] [Abstract][Full Text] [Related]
53. Are all melanomas dangerous?
Nørgaard C; Glud M; Gniadecki R
Acta Derm Venereol; 2011 Sep; 91(5):499-503. PubMed ID: 21874217
[TBL] [Abstract][Full Text] [Related]
54. A population-based study of cutaneous melanoma in Alberta, Canada (1993-2002).
Metelitsa AI; Dover DC; Smylie M; de Gara CJ; Lauzon GJ
J Am Acad Dermatol; 2010 Feb; 62(2):227-32. PubMed ID: 20018405
[TBL] [Abstract][Full Text] [Related]
55. Incidence and survival in patients with cutaneous melanoma by morphology, anatomical site and TNM stage: a Danish Population-based Register Study 1989-2011.
Bay C; Kejs AM; Storm HH; Engholm G
Cancer Epidemiol; 2015 Feb; 39(1):1-7. PubMed ID: 25468643
[TBL] [Abstract][Full Text] [Related]
56. [Epidemiology of cutaneous melanoma: descriptive data in France and Europe].
Grange F
Ann Dermatol Venereol; 2005 Dec; 132(12 Pt 1):975-82. PubMed ID: 16446640
[TBL] [Abstract][Full Text] [Related]
57. Cutaneous malignant melanoma in children and adolescents in Sweden, 1993-2002: the increasing trend is broken.
Karlsson PM; Fredrikson M
Int J Cancer; 2007 Jul; 121(2):323-8. PubMed ID: 17372908
[TBL] [Abstract][Full Text] [Related]
58. Nodular melanomas: analysis of the casistic and relationship with thick melanomas and diagnostic delay.
Betti R; Martino P; Vergani R; Gualandri L; Crosti C
J Dermatol; 2008 Oct; 35(10):643-50. PubMed ID: 19017043
[TBL] [Abstract][Full Text] [Related]
59. [Melanoma mortality in switzerland 1970-1986].
Angst E; Bisig B; Tschopp A; Sigg C; Schüler G; Gutzwiller F; Schnyder UW
Schweiz Med Wochenschr; 1989 Nov; 119(45):1591-8. PubMed ID: 2814415
[TBL] [Abstract][Full Text] [Related]
60. Conditional survival of malignant melanoma in The Netherlands: 1994-2008.
van der Leest RJ; van Steenbergen LN; Hollestein LM; de Vries E; Nijsten T; van Akkooi AC; Janssen-Heijnen ML; Coebergh JW
Eur J Cancer; 2014 Feb; 50(3):602-10. PubMed ID: 24262585
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
